Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1264 Views
-
Last post by frodo
-
- 0 Replies
- 932 Views
-
Last post by frodo
-
- 0 Replies
- 2259 Views
-
Last post by NHE
-
- 0 Replies
- 1242 Views
-
Last post by frodo
-
- 0 Replies
- 1196 Views
-
Last post by frodo
-
- 0 Replies
- 1156 Views
-
Last post by frodo
-
- 0 Replies
- 1401 Views
-
Last post by NHE
-
- 0 Replies
- 438 Views
-
Last post by NHE
-
- 1 Replies
- 2866 Views
-
Last post by Tif